Company intelligence / Profile preview
B-Crobes
Putrajaya, Wilayah Persekutuan, Malaysiabcrobes.com ↗
- Ownership
- Private
- Employees
- ~49
- Development stage
- Other
01
Overview
B-Crobes has developed proprietary probiotic strains supported by over 20 clinical studies. Their flagship product HEXBIO is registered with the National Pharmaceutical Control Bureau and is widely used for gut health and adjunctive management of gastrointestinal symptoms. The company exports to 15 countries and aims for global leadership in science-backed microbial therapeutics.
- Therapeutic areas
- PsychiatryGastroenterologyCardiovascularOther
- Modalities
- Microbial therapyLive biotherapeutic product therapyProbiotic (as a subcategory of microbial therapy)
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Beyond the preview
Go deeper on B-Crobes.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on B-Crobes.